In this 40-minute archived webinar, presented by QPS Neuropharmacology, you will learn about validated transgenic and non-transgenic in vitro and in vivo models covering most targets of AD, PD, HD and other neurodegenerative diseases.
It’s brought to you by ADDF ACCESS, a program of the ADDF and Science Exchange, as part of our commitment to connect researchers developing CNS drugs with technologies that can help accelerate breakthrough discoveries.
This video, as well as many other educational resources providing guidance on CNS drug discovery, can be found in the ADDF ACCESS library.
Watch the video of the webinar:
You will learn:
- When to use animal models in your drug discovery program
- How to choose the most appropriate animal model for your therapeutic or mechanism of action
- How to design the most efficient “first-pass” proof-of-concept study
- Best practices for submitting compounds and sample requirements for a successful study
